NEW YORK (GenomeWeb News) – Cancer geneticist Janet Rowley has died at the age of 88, according to the University of Chicago, where she discovered genetic aberrations involved in leukemia, which led to new treatments such as Gleevec (imatinib).

The University noted this week that Rowley made a series of fundamental discoveries during her career that demonstrated how specific chromosomal changes caused certain types of cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.